BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9305960)

  • 1. Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1.
    Kent UM; Hanna IH; Szklarz GD; Vaz AD; Halpert JR; Bend JR; Hollenberg PF
    Biochemistry; 1997 Sep; 36(39):11707-16. PubMed ID: 9305960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole.
    Kent UM; Bend JR; Chamberlin BA; Gage DA; Hollenberg PF
    Chem Res Toxicol; 1997 May; 10(5):600-8. PubMed ID: 9168259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies with N-benzyl-1-aminobenzotriazole-inactivated CYP2B1: differential effects on the metabolism of 7-ethoxy-4-(trifluoromethyl)coumarin, testosterone, and benzphetamine.
    Kent UM; Pascual L; Roof RA; Ballou DP; Hollenberg PF
    Arch Biochem Biophys; 2004 Mar; 423(2):277-87. PubMed ID: 15001392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amino acid residues involved in the inactivation of cytochrome P450 2B1 by two acetylenic compounds: the role of three residues in nonsubstrate recognition Sites.
    Von Weymarn LB; Sridar C; Hollenberg PF
    J Pharmacol Exp Ther; 2004 Oct; 311(1):71-9. PubMed ID: 15178696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
    Goosen TC; Mills DE; Hollenberg PF
    J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the differences in lidocaine binding and regioselectivity of oxidation by cytochromes P450 2B1 and 2B2.
    Hanna IH; Roberts ES; Hollenberg PF
    Biochemistry; 1998 Jan; 37(1):311-8. PubMed ID: 9425052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis.
    Lin HL; Kent UM; Zhang H; Waskell L; Hollenberg PF
    J Pharmacol Exp Ther; 2004 Dec; 311(3):855-63. PubMed ID: 15302894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the active site of cytochrome P450 2B1: metabolism of 7-alkoxycoumarins by the wild type and five site-directed mutants.
    Kobayashi Y; Fang X; Szklarz GD; Halpert JR
    Biochemistry; 1998 May; 37(19):6679-88. PubMed ID: 9578551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1.
    Roberts ES; Lin Hl; Crowley JR; Vuletich JL; Osawa Y; Hollenberg PF
    Chem Res Toxicol; 1998 Sep; 11(9):1067-74. PubMed ID: 9760281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of cytochrome P450 2B1 inactivation by xanthates.
    Yanev SG; Kent UM; Roberts ES; Ballou DP; Hollenberg PF
    Arch Biochem Biophys; 2000 Jun; 378(1):157-66. PubMed ID: 10871056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.
    He K; Falick AM; Chen B; Nilsson F; Correia MA
    Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins.
    Koenigs LL; Trager WF
    Biochemistry; 1998 Sep; 37(38):13184-93. PubMed ID: 9748325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
    Sinal CJ; Bend JR
    Drug Metab Dispos; 1996 Sep; 24(9):996-1001. PubMed ID: 8886610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities.
    Hanna IH; Teiber JF; Kokones KL; Hollenberg PF
    Arch Biochem Biophys; 1998 Feb; 350(2):324-32. PubMed ID: 9473308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity and kinetics of inactivation of rabbit hepatic cytochromes P450 2B4 and 2B5 by N-aralkylated derivatives of 1-aminobenzotriazole.
    Grimm SW; Bend JR; Halpert JR
    Drug Metab Dispos; 1995 May; 23(5):577-83. PubMed ID: 7587934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic properties of an expressed cytochrome P450 2B1 from a Wistar-Kyoto rat liver cDNA library.
    Kobayashi Y; Strobel SM; Hopkins NE; Alworth WL; Halpert JR
    Drug Metab Dispos; 1998 Oct; 26(10):1026-30. PubMed ID: 9763409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite.
    Lin HL; Kent UM; Zhang H; Waskell L; Hollenberg PF
    Chem Res Toxicol; 2003 Feb; 16(2):129-36. PubMed ID: 12588183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of cytochrome P450 2B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables.
    Goosen TC; Kent UM; Brand L; Hollenberg PF
    Chem Res Toxicol; 2000 Dec; 13(12):1349-59. PubMed ID: 11123978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P-450 in vivo.
    Knickle LC; Philpot RM; Bend JR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):377-85. PubMed ID: 8035335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.